☆ 4.2 Article

Time Course of Coagulopathy Evaluated with Rotational Thromboelastometry in Patients with Severe Coronavirus Disease 2019

INTERNAL MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?

C. Ibanez et al.

Summary: In COVID-19 patients, a hypercoagulable state with decreased fibrinolytic capacity is observed in ROTEM profiles despite increased D-dimer levels, suggesting lungs may be the main source of D-dimer while a systemic hypofibrinolytic state coexists. Future studies should confirm this hypothesis.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Add to Collection

Article Critical Care Medicine

Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study

Luke Wallace Collett et al.

Summary: This study found that critically ill adults with COVID-19-associated respiratory failure exhibit a hypercoagulable state in the intensive care unit, characterized by supranormal clot firmness, minimal clot lysis, and elevated fibrinogen.

AUSTRALIAN CRITICAL CARE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Rotational thromboelastometry results are associated with care level in COVID-19

Lou M. Almskog et al.

Summary: High prevalence of thrombotic events in severely ill COVID-19 patients has been reported, with hypercoagulopathy being present early in patients with mild to moderate disease and more pronounced in severe cases. ROTEM variables at admission show hypercoagulopathy, more prominent in patients with increased disease severity, suggesting that further studies are needed to predict the risk of thromboembolic complications.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Add to Collection

Review Critical Care Medicine

COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management

Michael A. Mazzeffi et al.

Summary: Patients with severe COVID-19 often develop hypercoagulability, which can improve with anticoagulant therapy. Viscoelastic coagulation testing provides an opportunity to tailor anticoagulant therapy based on individual coagulation status.

SHOCK (2021)

Add to Collection

Letter Critical Care Medicine

Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU

Christina Creel-Bulos et al.

SHOCK (2021)

Add to Collection

Review Surgery

Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications

Jonathan P. Meizoso et al.

Summary: The COVID-19 pandemic poses a global public health threat with severe cases often marked by ARDS caused by microvascular thrombosis. The hypercoagulability and fibrinolysis shutdown seen in COVID-19 patients are distinctive features that require careful study for potential therapeutic interventions. Understanding the molecular mechanisms behind these dysfunctions is crucial for improving outcomes for severe COVID-19 patients.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)

Add to Collection

Article Critical Care Medicine

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Julie Helms et al.

INTENSIVE CARE MEDICINE (2020)

Add to Collection

Article Surgery

Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection

Franklin L. Wright et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia

Vittorio Pavoni et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

Add to Collection

Article Medicine, General & Internal

COVID-19: The crucial role of blood coagulation and fibrinolysis

Sergio Coccheri

INTERNAL AND EMERGENCY MEDICINE (2020)

Add to Collection

Letter Medicine, General & Internal

Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)

Julien Nahum et al.

JAMA NETWORK OPEN (2020)

Add to Collection

Article Hematology

Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis

Christophe Nougier et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Review Hematology

Coagulopathy in COVID-19

Toshiaki Iba et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Letter Hematology

Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry

Rahul Chaudhary et al.

THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Hematology

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

F. A. Klok et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Review Medicine, General & Internal

COVID-19 Infection-Related Coagulopathy and Viscoelastic Methods: A Paradigm for Their Clinical Utility in Critical Illness

Argirios E. Tsantes et al.

DIAGNOSTICS (2020)

Add to Collection

Article Critical Care Medicine

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

Jan Matthias Kruse et al.

CRITICAL CARE (2020)

Add to Collection

Article Critical Care Medicine

Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery

Alexander Hincker et al.

CRITICAL CARE (2014)

Add to Collection

© Peeref 2019-2024. All rights reserved.